Interpace Biosciences Implements Reverse Stock Split for Nasdaq Uplisting Bid

Interpace Biosciences executed a reverse stock split as part of its strategic efforts to satisfy exchange requirements and facilitate a proposed move to the Nasdaq stock exchange.